Ledger.Open graph →
SEC Form D · filed September 19, 2024

Metabolics Pharma, Inc

Offering
$6.3M
Sold
$5.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PHILADELPHIA, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Jay A. Brammer · Philadelphia, PADirectorMark A. Kamp · Philadelphia, PADirectorJohn A. Dessouki · Philadelphia, PAExec · DirectorMark A. Finn · Philadelphia, PADirectorBarry A. Miller · Philadelphia, PADirectorRichard Larson · Somerville, MAExec · DirectorMark A. Kamp · Philadelphia, PADirectorJohn A. Dessouki · Philadelphia, PAExec · DirectorMark A. Finn · Philadelphia, PADirectorBarry A. Miller · Philadelphia, PADirectorJay A. Brammer · Philadelphia, PADirectorRichard Larson · Somerville, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗